Corticosteroids are the mainstay of treatment of all asthma severity levels in adults and
children. With their widespread use comes a responsibility to monitor, understand, and …

Asthma is a chronic inflammatory disease of the airways that affects a growing number of
children and adolescents. Inhaled corticosteroids (ICS) are the mainstay of treatment in …

Inhaled corticosteroids (ICS) have become the mainstay of therapy in chronic childhood
asthma. Despite the long history and the documented efficacy of these drugs in controlling …

Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents available for
the treatment of asthma and represent the mainstay of therapy for most patients with the …

Inhaled corticosteroids (ICS) are currently the mainstay of therapy in persistent childhood
asthma. However, systemic adverse effects of various available agents-particularly on …

Inhaled corticosteroids (ICS) are now first‐line therapy for persistent asthma in children. The
major safety concerns of long‐term ICS therapy for childhood asthma are potential effects on …

Asthma is the most common chronic inflammatory disease of children, and inhaled
corticosteroids (ICSs) are the most effective and commonly used treatment of persistent …

The severe adverse effects of chronic oral corticosteroids, including suppression of the
hypothalamo-pituitary-adrenal (HPA) axis, growth failure, and delays in skeletal maturation …

The evidence for hypothalamic‐pituitary‐adrenal axis (HPA) suppression by inhaled
corticosteroids (ICS) was found to be conflicting. Reviewers have not distinguished between …

For the vast majority of asthmatic children, treatment with inhaled glucocorticoids is safe and
effective. Mild impairment of adrenal function of doubtful clinical significance is known to …